Cardiovascular disorder

Related records

Broader conditions (3)

• Disease
• Disease by body system or component
• Human disease

Narrower conditions (1,626)

• 22q11.2 deletion syndrome
• 46,XY complete gonadal dysgenesis
• 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
• 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome
• 46,XY sex reversal 1
• 46,XY sex reversal 10
• 46,XY sex reversal 11
• 46,XY sex reversal 2
• 46,XY sex reversal 3
• 46,XY sex reversal 4
• 46,XY sex reversal 5
• 46,XY sex reversal 6
• 46,XY sex reversal 7
• 46,XY sex reversal 9
• 6q25.1 microdeletion syndrome
• 8q24.3 microdeletion syndrome
• AA amyloidosis
• Abdominal aortic aneurysm
• Abdominal cystic lymphangioma
• Aberrant subclavian artery

Trials (1,265)

• "Breathlessness Diagnostics in a Box" (BiaB) for Primary Care. A Multi-country Quality Improvement Project Using a Randomized Stepped-wedge Design
• "Hjerteloeftet" ("HeartLift"). Interaction For Preventing Cardiovascular Disease
• [E]PANOVA Combined With a [S]TATIN in [P]ATIENTS With HYPERT[R]IGLYCER[I]DEMIA to Reduce Non-HDL CHOLES[T]EROL
• 7 Year Follow-up Study of the DanRisk Population
• A Clinical and Histological Analysis of Mesenchymal Stem Cells in Amputation
• A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)
• A Clinical Trial of SystemCHANGE to Improve Exercise, Diet and Health in HIV-Infected Adults
• A Complex Contraception Registry
• A Culture-Centered Approach to Promoting Women's Heart Health in Singapore
• A Genomic Approach for Clopidogrel in Caribbean Hispanics
• A Human Trial to Assess the Low Density Lipoprotein Cholesterol (LDL-C) Lowering Effect of Soy
• A Multi-center Study on Artificial Intelligence-Based Quantitative Evaluation of Echocardiography
• A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
• A New Operation for the Treatment for Long-standing Atrial Fibrillation
• A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
• A Nurse-led Intervention to Extend the Veteran HIV Treatment Cascade for Cardiovascular Disease Prevention
• A Personalized Dashboard to Educate Veterans at Risk of Stroke
• A Phase I, Safety Tolerability and Pharmacokinetics of AZD4831 to Treat Cardiovascular Disease
• A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging
• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Approved drugs (193)

• Acebutolol
• Acetyldigitoxin
• Acipimox
• Adenosine
• Alipogene tiparvovec
• Alirocumab
• Aliskiren
• Alprostadil
• Amiloride
• Amlodipine
• Angiotensin II
• Arbutamine
• Atenolol
• Atorvastatin
• Bamethan
• Bempedoic acid
• Benazepril
• Bendroflumethiazide
• Benziodarone
• Bepridil

Drugs in development (240)

• 1.ALPHA.-hydroxyvitamin D5 Phase 1
• 3,5-diiodothyropropionic acid Phase 2
• Acadesine Phase 3
• Acarbose Phase 3
• Acoramidis Phase 3
• Alagebrium chloride Phase 2
• Albuterol sulfate Phase 1
• Allopurinol Phase 3
• Alprenolol Phase 2
• ALT-2074 Phase 2
• Alteplase Phase 3
• Aluminum clofibrate Phase 2
• Amezinium metilsulfate Phase 2
• Angiotensin amide Phase 2
• Anti-inhibitor coagulant complex Phase 1
• Apabetalone Phase 3
• Apocynin Phase 1
• Arginine Phase 3
• Aspirin Phase 3
• Aspirin trelamine Phase 1

Other linked drugs (21)

• Alacepril
• Caficrestat
• Empagliflozin
• Epoprostenol
• Esomeprazole
• Fenofibric acid
• Ferrous sulfate
• Fondaparinux sodium
• Formoterol
• Gitalin
• Iodixanol
• Iopamidol
• Ioversol
• Ioxaglic acid
• Macitentan
• Perflenapent
• Perflexane
• Sennosides
• Sulfur hexafluoride
• Tiapamil